Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study

Ogawa, Eiichi; Jun, Dae Won; Toyoda, Hidenori; Hsu, Yao‐Chun; Yoon, Eileen L.; Ahn, Sang Bong; Yeh, Ming‐Lun; Do, Son; Trinh, Huy N.; Takahashi, Hirokazu; Enomoto, Masaru; Kawada, Norifumi; Yasuda, Satoshi; Tseng, Cheng‐Hao; Kawashima, Keigo; Lee, Han Ah; Inoue, Kaori; Haga, Hiroaki; Do, Ai‐Thien; Maeda, Mayumi; Hoang, Joseph H.; Cheung, Ramsey; Ueno, Yoshiyuki; Eguchi, Yuichiro; Furusyo, Norihiro; Yu, Ming‐Lung; Tanaka, Yasuhito; Nguyen, Mindie H.

doi:10.1111/apt.17785

Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study

Summary Background Data on patients switched to tenofovir alafenamide (TAF) from nucleos(t)ide analogues (NUCs) other than tenofovir disoproxil fumarate are limited. Aims To assess the treatment and renal/bone safety outcomes following the switch to TAF. Methods We prospectively enrolled adult pa…